(Q34646469)

3 August 2017

1 reference

title

Ammonia and Alzheimer's disease (English)

1 reference

3 August 2017

0 references

0 references

Nikolaus Seiler

1

1 reference

3 August 2017

publication date

1 August 2002

1 reference

Neurochemistry International

3 August 2017

published in

1 reference

3 August 2017

volume

41

1 reference

3 August 2017

issue

2-3

1 reference

3 August 2017

page(s)

189-207

1 reference

Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Excitatory amino acids and memory: evidence from research on Alzheimer's disease and behavioral pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Oxidative modification of glutamine synthetase by amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Specific inhibition by NH4CL of autophagy-associated proteloysis in cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effect of ammonia on endocytosis, cytokine production and lysosomal enzyme activity of a microglial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effect of ammonia on endocytosis and cytokine production by immortalized human microglia and astroglia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Increased tryptophan uptake into the brain in hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effect of ammonia on GABA uptake and release in cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cytokines and inflammatory proteins in alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Somatostatin in Alzheimer's disease and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The genetics of Alzheimer disease: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Quinolinic acid neurotoxicity in the nucleus basalis antagonized by kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Symptomatic and neuroprotective properties of the aliphatic propargylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Blood ammonia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effects of hyperammonaemia on brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Complications of cirrhosis III. Hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Delayed induction of apoptosis by ammonia in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Biochemistry and physiology of brain ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Glutamatergic neurotransmission in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Membrane alterations in Alzheimer's disease and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Loss of high-affinity agonist receptor binding in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Assessment of genetic risk for Alzheimer's disease among first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonium injection induces an N-methyl-D-aspartate receptor-mediated proteolysis of the microtubule-associated protein MAP-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Hyperammonemia in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Hyperammonemia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cortical abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain signal transduction disturbances in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Neurotransmitters and second messengers in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Astroglia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Coronal reconstruction images of glucose metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Nicotinic Cholinergic Receptors in Human Brain: Effects of Aging and Alzheimer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonium ion interferes with the lysosomal degradation of glycosaminoglycans in cultures of human glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Aluminium in Alzheimer's?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonia inhibits phagosome–lysosome fusion in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

A hypothesis concerning the role of endogenous colchicine-like factors in the etiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Glutamate transmission and toxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Blood-Brain Barrier Abnormalities in Alzheimer's Diseasea

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Manganese intoxication and chronic liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Hepatic encephalopathy: An update of pathophysiologic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Characterization of N-methyl-d-aspartate receptors in the hyperammonemic sparse fur mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Possible role of ammonia in the brain in dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Organic brain syndrome and aging. A six-year follow-up of surviving twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Lipid peroxidation and free radical scavengers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Changes in G protein-mediated signal transduction in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alpha-2 macroglobulin gene in early- and late-onset Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonia metabolism in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Patterns of synaptic and nerve cell pathology in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Mechanisms of lysosomal enzyme secretion by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effects of a MAO-B inhibitor in the treatment of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The role of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alzheimer's disease: a 'cobalaminergic' hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alzheimer's disease: membrane-associated metabolic changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The importance of inflammatory mechanisms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alterations in glucose metabolism in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

GABAA receptor beta 2 and beta 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Expression of monoamine oxidase B activity in astrocytes of senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

In vivo detection of neurotransmitter changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The role of astrocytes in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Astroglial dysfunction in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Abnormalities in muscarinic cholinergic receptors and their G-protein coupling systems in the cerebral frontal cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

NGF and the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Monoamine neurons in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cytochrome oxidase deficiency in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Magnetic resonance spectroscopic changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Some Speculations about Prions, Amyloid, and Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Synaptic transmission in ammonia intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Neurochemistry of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Free radicals in the genesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Herpes simplex virus: a role in the aetiology of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Hyperactivation of signal transduction systems in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

59 Inhibitors of lysosomal function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Is ammonia a pathogenetic factor in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ornithine aminotransferase, a potential target for the treatment of hyperammonemias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The origins of Alzheimer disease: a is for amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Notch and presenilins in vertebrates and invertebrates: implications for neuronal development and degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Aberrant phosphoinositide metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Protein oxidation in aging brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain quinolinic acid in Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Alterations in Brain Monoamine Oxidase Activity in Aging, Alzheimer's Disease, and Pick's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Apolipoprotein E and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ganglioside loss is a primary event in Alzheimer disease type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain glucose metabolism in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Intralysosomal pH and release of lysosomal enzymes in the rat liver after exhaustive exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Protective actions of L-carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Ammonia regulation of phosphate-activated glutaminase displays regional variation and impairment in the brain of aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

The basal ganglia and portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Tryptophan degradation and immune activation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

Apoptosis in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2802%2900041-4

7 January 2021

10.1016/S0197-0186(02)00041-4

Identifiers

DOI

1 reference

3 August 2017

1 reference